(PharmaNewsWire.Com, July 31, 2019 ) Growing demand for advanced veterinary infectious disease diagnostic tools, increasing demand for animal-derived food products, growth in companion animal population, rising demand for pet insurance, increasing number of veterinary practitioners in developed economies, and growing disease control & disease prevention measures are some of the key factors driving the veterinary infectious disease diagnostics market growth.
Immunodiagnostics was the most extensively used technology in the veterinary infectious disease diagnostics market
Based on technology, the veterinary infectious disease diagnostics market is segmented into immunodiagnostics, molecular diagnostics, and other technologies. In 2018, the immunodiagnostics segment accounted for the largest market share in the majorly due to the advancements in immunoassay formats, growing demand for early disease detection & diagnosis, increasing demand for rapid diagnosis, rising preference for in-house testing, and the increasing applications of immunodiagnostics.
Reference laboratories to register the highest CAGR in the veterinary infectious disease diagnostics market, by the end-user, during the forecast period
Based on the end-user, the veterinary infectious disease diagnostics market is segmented into reference laboratories, veterinary hospitals & clinics, point of care (POC) / in-house testing, and research institutes & universities. Reference laboratories are likely to be the largest end-user due to a large number of samples received for analysis as well as the growing demand for point-of-care (POC) / in-house testing. Due to the advantages of rapid detection and need for early diagnosis, the point of care (POC) / in-house testing is expected to register the highest CAGR in the market.
North America accounted for the largest share of the veterinary infectious disease diagnostics market in 2018
The veterinary infectious disease diagnostics market is segmented into five regional segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the veterinary infectious disease diagnostics market in 2018 owing to factors such as the presence of key market players in the region, increasing product offerings, greater affordability, and rising demand for early diagnosis.
The major players operating in the veterinary infectious disease diagnostics market are IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), QIAGEN N.V. (Indical GmbH) (Germany), Thermo Fisher Scientific, Inc. (US), Neogen Corporation (US), Virbac (France), bioMérieux SA (France), IDVet (France), Randox Laboratories, Ltd. (UK), Heska Corporation (US), Creative Diagnostics (US), URIT Medical Electronic Group Co., Ltd (China), NTBIO Diagnostics, Inc. (Canada), Bio-X Diagnostics (Belgium), Agrolabo S.p.A (Italy), Eurolyser Diagnostica (Austria), Eurofins Technologies (Hungary), MEGACOR Diagnostik GmbH (Austria), AusDiagnostics Pty, Ltd. (Australia), Demedetic Diagnostics GmbH (Germany), Chembio Diagnostic Systems, Inc. (US), DRG Diagnostics GmbH (Germany), XpressBio (US), InBios International, Inc. (US), and Genesig (Primerdesign) (UK).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
